Digital chronic condition management company DarioHealth announced it has entered into a strategic commercial agreement with GreenKey Health, a company focused on obstructive sleep apnea.The alliance combines Dario’s cardiometabolic and behavioral artificial intelligence-powered health…
Continue Reading
What You Should Know:
– Sleep Cycle, a sleep technology company, announced the commencement of a clinical study to validate its forthcoming smartphone-based feature for screening and monitoring obstructive sleep apnea (OSA).
– The feature will…
Continue Reading
What You Should Know:
– Dreem Health, a leading digital sleep clinic managed by The Sunrise Group, has announced a strategic partnership with Humana, one of the United States’ foremost health and well-being companies.
– Effective immediately,…
Continue Reading
R. Kirk Huntsman, Chairman and CEO, Co-Founder at Vivos Therapeutics
Sleep is essential, yet millions worldwide unknowingly suffer from sleep disorders, especially Obstructive Sleep Apnea (OSA), which contributes to up to 40 severe health complications…
Continue Reading
Samsung announced a joint research initiative with Stanford Medicine to enhance the Galaxy Watch’s sleep apnea detection feature and create new AI-enabled innovations for proactive care.The sleep apnea detection feature, which received FDA De…
Continue Reading
Source: Samsung
What You Should Know:
– Samsung Electronics and Stanford University today forms a research collaboration with Stanford Medicine aimed at developing health solutions leveraging Samsung’s recently FDA De Novo authorized obstructive sleep apnea (OSA)…
Continue Reading
GEM HEALTH, a virtual sleep care company, has raised $7 million in Series A funding, which will help the startup expand its sleep services, it announced on Tuesday.
Minneapolis, Minnesota-based GEM HEALTH treats patients in…
Continue Reading
Breakthrough in Sleep Apnea Management
The FDA has marked a historic milestone by approving the first pharmaceutical treatment option for certain patients with obstructive sleep apnea. Dr. Sally Seymour, director of the FDA’s division of…
Obstructive sleep apnea (OSA) is a serious, chronic sleep-related breathing disease that impacts an estimated 80 million people in the United States and nearly 1 billion globally. Untreated OSA carries profound health and quality-of-life…
Continue Reading
